Prevalence of Protease and Reverse Transcriptase Drug Resistance Mutations over Time in Drug-Naïve Human Immunodeficiency Virus Type 1-Positive Individuals in Rio de Janeiro, Brazil
Open Access
- 1 September 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (9) , 3075-3079
- https://doi.org/10.1128/aac.46.9.3075-3079.2002
Abstract
The prevalence of mutations that confer resistance to protease inhibitors and to nucleoside and nonnucleoside reverse transcriptase inhibitors in 49 blood samples from drug-naïve human immunodeficiency virus type 1-infected blood donors living in Rio de Janeiro state, Brazil, in 1998 was evaluated genotypically and phenotypically.Keywords
This publication has 33 references indexed in Scilit:
- Analysis of HIV Type 1 Protease and Reverse Transcriptase Sequences from Venezuela for Drug Resistance-Associated Mutations and Subtype Classification: A UNAIDS StudyAIDS Research and Human Retroviruses, 2001
- Analysis of prevalence of HIV-1 drug resistance in primary infections in the United KingdomBMJ, 2001
- Primary Genotypic and Phenotypic HIV-1 Drug Resistance in Recent Seroconverters in MadridJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Resistance to antiretroviral drugs in patients with primary HIV-1 infectionInternational Journal of Antimicrobial Agents, 2000
- Reduced Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) from Patients with Primary HIV Infection to Nonnucleoside Reverse Transcriptase Inhibitors Is Associated with Variation at Novel Amino Acid SitesJournal of Virology, 2000
- Prevalence of Mutations Associated with Reduced Antiretroviral Drug Susceptibility among Human Immunodeficiency Virus Type 1 Seroconverters in the United States, 1993–1998The Journal of Infectious Diseases, 2000
- The HIV Epidemic in the Amazon Basin Is Driven by Prototypic and Recombinant HIV-1 Subtypes B and FJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug useAIDS, 2000
- Dual and Recombinant Infections: An Integral Part of the HIV-1 Epidemic in BrazilEmerging Infectious Diseases, 1999
- Genetic heterogeneity of the V3 region of the HIV-1 envelope glycoprotein in BrazilAIDS, 1993